This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Zhao, Z., Zhao, S., Luo, L., Xiang, Q., Zhu, Z., Wang, J. et al. miR-199b-5p-DDR1-ERK signalling axis suppresses prostate cancer metastasis via inhibiting epithelial-mesenchymal transition. Br. J. Cancer 124, 982–994 (2021).
Chao, A., Tsai, C. L., Wei, P. C., Hsueh, S., Chao, A. S., Wang, C. J. et al. Decreased expression of microRNA-199b increases protein levels of SET (protein phosphatase 2A inhibitor) in human choriocarcinoma. Cancer Lett. 291, 99–107 (2010).
Cristóbal, I., Caramés, C., Rincón, R., Manso, R., Madoz-Gúrpide, J., Torrejón, B. et al. Downregulation of microRNA-199b predicts unfavorable prognosis and emerges as a novel therapeutic target which contributes to PP2A inhibition in metastatic colorectal cancer. Oncotarget 8, 40169–40180 (2017).
Hu, X., Garcia, C., Fazli, L., Gleave, M., Vitek, M. P., Jansen, M. et al. Inhibition of Pten deficient castration resistant prostate cancer by targeting of the SET–PP2A signaling axis. Sci. Rep. 5, 15182 (2015).
González-Alonso, P., Cristóbal, I., Manso, R., Madoz-Gúrpide, J., García-Foncillas, J. & Rojo, F. PP2A inhibition as a novel therapeutic target in castration-resistant prostate cancer. Tumour Biol. 36, 5753–5755 (2015).
Cristóbal, I., Torrejón, B., Rubio, J., Santos, A., Pedregal, M., Caramés, C. et al. Deregulation of SET is associated with tumor progression and predicts adverse outcome in patients with early-stage colorectal cancer. J. Clin. Med. 8, 346 (2019).
Mody, H. R., Hung, S. W., Naidu, K., Lee, H., Gilbert, C. A., Hoang, T. T. et al. SET contributes to the epithelial-mesenchymal transition of pancreatic cancer. Oncotarget 8, 67966–67979 (2017).
Liu, C. Y., Huang, T. T., Chen, Y. T., Chen, J. L., Chu, P. Y., Huang, C. T. et al. Targeting SET to restore PP2A activity disrupts an oncogenic CIP2A-feedforward loop and impairs triple negative breast cancer progression. eBioMedicine 40, 263–275 (2019).
Shen, Q., Cicinnati, V. R., Zhang, X., Iacob, S., Weber, F., Sotiropoulos, G. C. et al. Role of microRNA-199a-5p and discoidin domain receptor 1 in human hepatocellular carcinoma invasion. Mol. Cancer 9, 227 (2010).
Zhong, J., Huang, R., Su, Z., Zhang, M., Xu, M., Gong, J. et al. Downregulation of miR-199a-5p promotes prostate adeno-carcinoma progression through loss of its inhibition of HIF-1alpha. Oncotarget 8, 83523–83538 (2017).
Author information
Authors and Affiliations
Contributions
I.C., A.S. and J.R. conceived the work and drafted the manuscript. F.R. and J.G.F. designed the work and revised the manuscript. All authors approved the final version of the manuscript and agACKreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Corresponding authors
Ethics declarations
Ethics approval and consent to participate
Not applicable.
Consent to publish
Not applicable.
Data availability
Not applicable.
Competing interests
The authors declare no competing interests.
Funding information
This work was supported by PI18/00382 and PI16/01468 grants from “Instituto de Salud Carlos III FEDER”.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Cristóbal, I., Santos, A., Rubio, J. et al. Comment on “miR-199b-5p-DDR1-ERK signalling axis suppresses prostate cancer metastasis via inhibiting epithelial-mesenchymal transition”. Br J Cancer 125, 618–619 (2021). https://doi.org/10.1038/s41416-021-01433-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41416-021-01433-7